At a glance
ClinicalIndex Comparison RecordPhase 2Completed· 164 enrolled
Drug / intervention
Bonipar +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Efficacy of a Topical Pain Relief Spray Containing Herbal Oil Extracts (Bonipar) Among Individuals With Acute and Chronic Musculoskeletal Pain
In Brief
A Phase 2 clinical trial evaluating Bonipar and Diclofenac sodium topical solution 1.5% for Chronic Pain and Musculoskeletal Pain. Completed, enrolled 164 participants across 1 site.
Detailed Summary
This study is a non-inferiority study comparing efficacy and onset of action between the herbal extracts topical solution, Bonipar, and diclofenac sodium topical solution, diclofenac topical solution 1.5%.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsChronic Pain, Musculoskeletal Pain
CountriesUnited States
Collaborators--
Timeline
Phase 2CompletedFinished
201820192020202120222023202420252026
First PostedMar 2018
Enrollment StartDec 2020
Primary CompletionSep 2022
TodayJul 2026
First PostedMar 20, 2018
Enrollment StartDec 15, 2020
Primary CompletionSep 22, 2022
TodayJul 2, 2026
Enrollment to primary: 1.8 yearsPosted 8.3 years ago
Interventions
Bonipardrug
Apply 2 pumps 2 times a day to be applied topically on the affected area during a two week treatment period.
Diclofenac sodium topical solution 1.5%drug
Apply 2 pumps 2 times a day to be applied topically on the affected area during a two week treatment period.